A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics

Experimental Hematology

Volumn 30, Issue 12, 2002, Pages 1428-1435

  Alenzi, Faris Q B ^a   Marley, Stephen B ^a   Lewis, John L ^a   Chandrashekran, Anil ^a   Warrens, Anthony N ^a   Goldman, John M ^a   Gordon, Myrtle Y ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; FAS ANTIGEN; FAS LIGAND; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL KINETICS; CELL PROLIFERATION; COLONY FORMING CELL; COLONY FORMING UNIT GM; CONTROLLED STUDY; DRUG EFFECT; GENE MUTATION; GENE TRANSFER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN FUNCTION; RETROVIRUS; WILD TYPE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BONE MARROW CELLS; CASPASES; CELL DIVISION; FAS LIGAND PROTEIN; HUMANS; KINETICS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MYELOID PROGENITOR CELLS; TRANSDUCTION, GENETIC;

UNIDENTIFIED RETROVIRUS;

EID: 0036899043     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00957-8     Document Type: Article

References (37)

1. Gordon M.Y., Blackett N.M. Reconstruction of the hematopoietic system after stem cell transplantation. Cell Transplant. 7:1998;339.
2. Gordon M.Y., Blackett N.M. Routes to repopulation - a unification of the stochastic model and separation of stem-cell subpopulations. Leukemia. 8:1994;1068.
3. De Maria R., Testa U., Luchetti L.et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood. 93:1999;796.
4. Traver D., Akashi K., Weissman I.L., Lagasse E. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity. 9:1998;47.
5. De Maria R., Zeuner A., Eramao A.et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature. 401:1999;489.
6. Zermati Y., Garrido C., Amsellem S.et al. Caspase activation is required for terminal erythroid differentiation. J Exp Med. 193:2001;247.
7. Zeuner A., Eramo A., Peschle C., De Maria R. Caspase activation without cell death. Cell Death Differ. 6:1999;1075.
8. Nicholson D.W., Thornberry N.A. Caspases. killer proteases Trend Biochem Sci. 22:1997;299.
9. Janicke R.U., Walker P.A., Lin X.Y., Porter A.G. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 15:1996;6969.
10. Fattman C.L., Delach S.M., Dou Q.P., Johnson D.E. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis. Oncogene. 20:2001;2918.
11. Browne S.J., MacFarlane M., Cohen G.M., Paraskeva C. The adenomatous polyposis coli protein and retinoblastoma protein are cleaved early in apoptosis and are potential substrates for caspases. Cell Death Differ. 5:1998;206.
12. Lewis JL, Nguyen DX, Wen B, et al. (2001) Contact-mediated inhibition of hematopoietic progenitor cells resulting from homotypic CD34-CD34 cell adhesion downregulates proteins of the pRb pathway. Blood 298:84a, (abstract 349).
13. Lewis J.L., Marley S.B., Blackett N.M., Szydlo R., Goldman J.M., Gordon M.Y. Interleukin 3 (IL-3) but not stem cell factor (SCF) increases self-renewal by human erythroid burst-forming units (BFU-E) in vitro. Cytokine. 10:1998;49.
14. Lewis J.L., Chinswangwatanakul W., Zheng B.et al. The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells. Blood. 97:2001;2604.
15. Lewis JL (2000) PhD Thesis. University of London.
16. Bae S.S., Choi J.H., Oh Y.S., Perry D.K., Ryu S.H., Suh P.G. Proteolytic cleavage of epidermal growth factor receptor by caspases. FEBS Lett. 491:2001;16.
17. Fantuzzi G., Dinarello C.A. Interleukin-18 and interleukin-1 β two cytokine substrates for ICE (caspase-1) J Clin Immunol. 19:1999;1.
18. Bruckheimer E.M., Kyprianou N. Dihydrotestosterone enhances transforming growth factor-β-induced apoptosis in hormone-sensitive prostate cancer cells. Endocrinology. 142:2001;2419.
19. Katsuda K., Kataoka M., Uno F.et al. Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. Oncogene. 21:2002;2108.
20. Steinman R.A., Johnson D.E. p21Waf1 prevents downmodulation of the apoptotic inhibitor protein c-IAP1 and inhibits leukemic apoptosis. Mol Med. 6:2000;736.
21. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:1992;314.
22. Brooks W.P., Lynes M.A. Effects of hemizygous CD45 expression in the autoimmune FasL (gld/gld) syndrome. Cell Immunol. 212:2001;24.
23. Fecho K., Bentley S.A., Cohen P.L. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis. Cell Immunol. 188:1998;19.
24. Schneider E., Moreau G., Arnould A.et al. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice. Blood. 94:1999;2613.
25. Gordon M.Y., Marley S.B., Lewis J.L.et al. Treatment with interferon-α preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM. J Clin Invest. 102:1998;710.
26. R gene. Exp Hematol. 26:1998;185.
27. Kong J., Ringer D.P. Quantitative in situ image analysis of apoptosis in well and poorly differentiated tumors from rat livers. Am J Pathol. 147:1995;1626.
28. Koury M.J. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol. 20:1992;391.
29. + human marrow cells is induced by interferon γ and tumor necrosis factor-α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 85:1995;3183.
30. Anthony R.S., McKelvie N.D., Craig J.I., Parker A.C. Fas antigen (CD95) expression in peripheral blood progenitor cells from patients with leukaemia and lymphoma. Leuk Lymphoma. 30:1998;449.
31. Nagafuji K., Shibuya T., Harada M.et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood. 86:1995;883.
32. Selleri C., Sato T., Del-Vecchio L.et al. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia. Blood. 89:1997;957.
33. Enari M., Hug H., Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:1995;78.
34. Chow S.C., Slee E.A., MacFarlane M., Cohen G.M. Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells. Exp Cell Res. 246:1999;491.
35. Coggle J.E., Gordon M.Y. Quantitative measurements on the hemopoietic systems of three strains of mice. Exp Hematol. 3:1975;181.
36. De Haan G., Van Zant G. Intrinsic and extrinsic control of hemopoietic stem cell numbers. mapping of a stem cell gene J Exp Med. 186:1997;529.
37. Muller-Sieberg C.E., Riblet R. Genetic control of the frequency of hematopoietic stem cells in mice. mapping of a candidate locus to chromosome 1 J Exp Med. 171:1996;1141.